Search Results

There are 12053 results for: content related to: Hepatitis B virus treatment: Which patients should be treated with nucleos(t)ide analogue?

  1. You have free access to this content
    HBV Trials and Treatments

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 647A–705A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26856

  2. You have free access to this content
    Poster Session 4: Hepatitis B Therapy

    Hepatology

    Volume 60, Issue S1, October 2014, Pages: 1088A–1128A,

    Version of Record online : 1 OCT 2014, DOI: 10.1002/hep.27532

  3. You have free access to this content
    Posters (Abstracts 264–2239)

    Hepatology

    Volume 66, Issue S1, October 2017, Pages: 149–1185,

    Version of Record online : 1 OCT 2017, DOI: 10.1002/hep.29501

  4. You have free access to this content
    AASLD Abstracts

    Hepatology

    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Version of Record online : 1 OCT 2012, DOI: 10.1002/hep.26040

  5. Review article: long-term safety of nucleoside and nucleotide analogues in HBV-monoinfected patients

    Alimentary Pharmacology & Therapeutics

    Volume 44, Issue 1, July 2016, Pages: 16–34, P. Lampertico, H. L. Y. Chan, H. L. A. Janssen, S. I. Strasser, R. Schindler and T. Berg

    Version of Record online : 19 MAY 2016, DOI: 10.1111/apt.13659

  6. You have free access to this content
    Poster Session IV (Abstracts 1638 – 2112)

    Hepatology

    Volume 64, Issue S1, October 2016, Pages: 811–1050,

    Version of Record online : 1 OCT 2016, DOI: 10.1002/hep.28800

  7. You have full text access to this OnlineOpen article
    First-line treatment of chronic hepatitis B with entecavir or tenofovir in ‘real-life’ settings: from clinical trials to clinical practice

    Journal of Viral Hepatitis

    Volume 19, Issue 6, June 2012, Pages: 377–386, S. Pol and P. Lampertico

    Version of Record online : 28 MAR 2012, DOI: 10.1111/j.1365-2893.2012.01602.x

  8. Tenofovir-based rescue therapy for chronic hepatitis B patients who had failed treatment with lamivudine, adefovir, and entecavir

    Journal of Gastroenterology and Hepatology

    Volume 30, Issue 10, October 2015, Pages: 1514–1521, Byung Gyu Kim, Seok Won Jung, Eun Hye Kim, Jae Hee Kim, Ju Hwan Park, Shi Jung Sung, Bo Ryung Park, Min-Ho Kim, Chang Jae Kim, Byung Uk Lee, Jae Ho Park, In Du Jeong, Sung-Jo Bang, Jung Woo Shin and Neung Hwa Park

    Version of Record online : 11 SEP 2015, DOI: 10.1111/jgh.12993

  9. You have free access to this content
    AASLD Abstracts 895–1142

    Hepatology

    Volume 48, Issue S1, October 2008, Pages: 707A–816A,

    Version of Record online : 24 SEP 2008, DOI: 10.1002/hep.22644

  10. Tenofovir-based alternate therapies for chronic hepatitis B patients with partial virological response to entecavir

    Journal of Viral Hepatitis

    Volume 22, Issue 8, August 2015, Pages: 675–681, L. Lu, B. Yip, H. Trinh, C. Q. Pan, S.-H. B. Han, C. C. Wong, J. Li, S. Chan, G. Krishnan, C. C. Wong and M. H. Nguyen

    Version of Record online : 24 NOV 2014, DOI: 10.1111/jvh.12368

  11. You have free access to this content
    HBeAg-negative chronic hepatitis B: why do I treat my patients with nucleos(t)ide analogues?

    Liver International

    Volume 34, Issue s1, February 2014, Pages: 120–126, Mauro Viganò, Giampaolo Mangia and Pietro Lampertico

    Version of Record online : 23 DEC 2013, DOI: 10.1111/liv.12401

  12. You have free access to this content
    Efficacy of tenofovir switch therapy for nucleos(t)ide-experienced patients with chronic hepatitis B

    Alimentary Pharmacology & Therapeutics

    Volume 41, Issue 11, June 2015, Pages: 1190–1199, A. O.-S. Lo, V. W.-S. Wong, G. L.-H. Wong, Y.-K. Tse, H.-Y. Chan and H. L.-Y. Chan

    Version of Record online : 31 MAR 2015, DOI: 10.1111/apt.13185

  13. You have free access to this content
    Poster Session 4: Stem Cell Biology; Varices and Bleeding

    Hepatology

    Volume 62, Issue S1, October 2015, Pages: 1195A–1215A,

    Version of Record online : 7 OCT 2015, DOI: 10.1002/hep.28243

  14. Tenofovir rescue regimen following prior suboptimal response to entecavir and adefovir combination therapy in chronic hepatitis B patients exposed to multiple treatment failures

    Journal of Medical Virology

    Volume 87, Issue 6, June 2015, Pages: 1013–1021, Qian Zhang, Tao Han, Cai-Yun Nie, Fu-Shuang Ha, Lei Liu and Hua Liu

    Version of Record online : 25 FEB 2015, DOI: 10.1002/jmv.24153

  15. You have free access to this content
    Poster Session 4: Portal Hypertension - Experimental

    Hepatology

    Volume 62, Issue S1, October 2015, Pages: 1181A–1195A,

    Version of Record online : 7 OCT 2015, DOI: 10.1002/hep.28242

  16. You have free access to this content
    High Genetic Barrier Nucleos(t)ide Analogue(s) for Prophylaxis From Hepatitis B Virus Recurrence After Liver Transplantation: A Systematic Review

    American Journal of Transplantation

    Volume 13, Issue 2, February 2013, Pages: 353–362, E. Cholongitas and G.V. Papatheodoridis

    Version of Record online : 8 NOV 2012, DOI: 10.1111/j.1600-6143.2012.04315.x

  17. You have free access to this content
    Cost–Utility Analysis of Tenofovir Disoproxil Fumarate in the Treatment of Chronic Hepatitis B

    Value in Health

    Volume 13, Issue 8, December 2010, Pages: 922–933, Helen Dakin, Anthony Bentley and Geoff Dusheiko

    Version of Record online : 3 SEP 2010, DOI: 10.1111/j.1524-4733.2010.00782.x

  18. Response to tenofovir monotherapy in chronic hepatitis B patients with prior suboptimal response to entecavir

    Journal of Viral Hepatitis

    Volume 19, Issue 3, March 2012, Pages: 213–219, C. Q. Pan, K.-Q. Hu, A. S. Yu, W. Chen, C. Bunchorntavakul and K. R. Reddy

    Version of Record online : 17 OCT 2011, DOI: 10.1111/j.1365-2893.2011.01533.x

  19. Tenofovir/entecavir monotherapy after hepatitis B immunoglobulin withdrawal is safe and effective in the prevention of hepatitis B in liver transplant recipients

    Transplant Infectious Disease

    Volume 17, Issue 5, October 2015, Pages: 695–701, I. Fernández, C. Loinaz, O. Hernández, M. Abradelo, A. Manrique, J. Calvo, M. Manzano, A. García, F. Cambra, G. Castellano and C. Jiménez

    Version of Record online : 3 OCT 2015, DOI: 10.1111/tid.12434

  20. You have free access to this content
    Optimal therapy of chronic hepatitis B: how do I treat my HBeAg-negative patients?

    Liver International

    Volume 35, Issue s1, January 2015, Pages: 107–113, Mauro Viganò, Federica Invernizzi and Pietro Lampertico

    Version of Record online : 22 DEC 2014, DOI: 10.1111/liv.12717